Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed Paclitaxel and Radiotherapy in NSCLC
NCT00178256Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Jun 1998
- Primary completion
- Dec 2012
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in non-small cell lung cancer (NSCLC), sponsored by University of Rochester. Started Jun 1998; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00178256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178256.